Mylan Laboratories Limited
INTotal marks
71
Live
26
Live %
36.6%
First filing
2010-11-23
Top NICE
5Pharmaceuticals
| Trademark | Status | NICE | Filed | Registered | App # |
|---|---|---|---|---|---|
| ACRIPTEGA | Pending | 5 | 2026-03-26 | — | 019338047 |
| VALCUTRIL | Registered | 5 | 2025-07-17 | 2026-03-11 | 322844 |
| GLYVIVA | Registered | 5 | 2024-12-02 | 2025-11-14 | TT/M/1/061335 |
| RIVORELTRIS | Registered | 5 | 2024-04-30 | 2025-02-21 | TT/M/1/060835 |
| ZUZMET | Registered | 5 | 2024-04-30 | 2025-02-21 | TT/M/1/060837 |
| VIZUMET | Registered | 5 | 2024-04-30 | 2025-02-21 | TT/M/1/060838 |
| AVRIDELA | Registered | 5 | 2023-12-06 | 2025-07-23 | KH/1786406/M |
| ZUZMET | Registered | 5 | 2023-08-14 | 2025-02-04 | 306518-01 |
| TAFICITA | Registered | 5 | 2023-07-14 | 2023-09-18 | PH4202300517343 |
| NEMATRIS | Registered | 5 | 2023-06-26 | 2024-01-03 | KH/108310/23 |
| NEMATRIS | Pending | 5 | 2023-06-26 | — | 48553 |
| LEDVIR | Pending | 5 | 2023-04-26 | — | MM/T/2021/018193 |
| MyDekla | Pending | 5 | 2023-04-26 | — | MM/T/2021/018196 |
| HepBest | Pending | 5 | 2023-04-26 | — | MM/T/2021/018197 |
| MyHep All | Registered | 5 | 2023-04-26 | 2026-03-20 | MM/T/2021/018194 |
| AVONZA | Pending | 5 | 2023-04-26 | — | MM/T/2021/018198 |
| DIMPLE | Pending | 5 | 2023-04-26 | — | MM/T/2021/018195 |
| VIANI | Cancelled | 5 | 2023-02-13 | — | KH/106784/23 |
| VIANI | Abandoned | 5 | 2023-02-13 | — | PH4202300503242 |
| VIANI | Registered | 5 | 2023-01-25 | 2023-07-14 | 47890 |
| DEMTIBI | Registered | 5 | 2022-11-22 | 2024-07-03 | KH/1712441/M |
| DESREM | Registered | 5 | 2020-08-10 | 2021-06-10 | 282347-01 |
| OTYCULF | Registered | 5 | 2020-02-03 | 2020-02-03 | 1523551 |
| MYGESTY | Registered | 5 | 2018-10-12 | 2019-06-27 | 269272-01 |
| AVONZA | Registered | 5 | 2017-06-23 | 2018-03-07 | TT/M/1/052903 |
| MyHep All | Registered | 5 | 2016-09-08 | 2017-08-01 | DZ/T/2016/003801 |
| SofVal | Cancelled | 5 | 2016-01-26 | — | KH/67418/16 |
| KOMEFAN | Registered | 5 | 2014-03-14 | 2021-10-15 | AP/M/2014/001972 |
| TESAQIN | Registered | 5 | 2014-03-14 | 2021-07-09 | AP/M/2014/001971 |
| ALBAVIR PED | Cancelled | 5 | 2012-02-15 | — | AP/M/2012/001322 |
| TRESLAM 40 | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001339 |
| RICOVIR-EM | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001307 |
| RICOVIR-L | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001305 |
| ANZAVIR | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001301 |
| TREZAV PED | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001320 |
| NISANODID 250 | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001337 |
| NEVIMAT | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001325 |
| ZOVILAM | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001326 |
| ZOVILAM PED | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001327 |
| TEEVIR | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001310 |
| EFAMAT 200 | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001332 |
| TERZALA | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001340 |
| ZIDOMAT | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001328 |
| TERZALA PED | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001341 |
| ZIDOMAT 100 | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001329 |
| DILASTAV 30 | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001333 |
| ALLTERA | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001313 |
| DILASTAV 40 | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001330 |
| LAMIMAT 300 | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001324 |
| STAVMAT 30 | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001317 |
| NISANODID | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001334 |
| TELURA | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001309 |
| ALLTERA 125 | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001314 |
| TREZAV | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001319 |
| ABAMAT PED | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001312 |
| EFAMAT 50 | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001315 |
| RINAVO | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001308 |
| EFAMAT | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001331 |
| KODRAVIR-CP | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001303 |
| LAMIMAT | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001323 |
| NISANODID 125 | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001335 |
| RICOVIR | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001304 |
| STAVMAT 40 | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001318 |
| TRESLAM 30 | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001338 |
| EFAMAT 100 | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001316 |
| ANZAVIR-R | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001302 |
| ABAMAT | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001311 |
| ALBAVIR | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001321 |
| NISANODID 200 | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001336 |
| RICOVIR-LN | Cancelled | 5 | 2012-02-13 | — | AP/M/2012/001306 |
| ALBAVIR PED | Cancelled | 5 | 2010-11-23 | 2011-09-28 | 10146909 |
Page 1